Over the course of 17 weeks, participants in this study will use an internet program designed for treating OCD. They will meet with a therapist 9 times during the treatment. All participants will receive the treatment.
Individuals with the following may be considered for the study:
Individuals with the following will not be considered for the study:
Do you have obsessive-compulsive disorder or think you might? Have you had trouble finding treatment for your OCD? Do you use the Internet? If you answered “yes” to these questions, you might be eligible to participate in a research study conducted by Dr. Kenneth Kobak of the Center for Psychological Consultation.
To participate in this study, you must be at least 18 years old, have OCD, and use or be willing to use the Internet. You will not be required to travel to participate in this study, as the BT Steps program is web-based and all coaching will take place via telephone. Participants will be compensated up to $250 for their participation.
If You Are Struggling With:
* Stress and Tension
* Feeling Helpless or Hopeless
* Other Emotional Problems
Recovery International can help you to help yourself!
Nancy Keuthen, PhD
Co-Director, Trichotillomania Clinic and Research Unit
Chief Psychologist, Obsessive-Compulsive Disorder Clinic
Massachusetts General Hospital
Associate Professor of Psychology
Harvard Medical School
When anxiety takes over, it interferes with your child’s ability to cope with fear, worry, and depression — and treatment is necessary.
Early intervention is critical. Waiting for your child to mature or grow out of these behaviors may not be the right approach. In some cases children may develop chronic anxiety and depression, which is often associated with substance abuse and other high-risk behaviors.
Martin Franklin, PhD
Associate Professor of clinical psychology in psychiatry
University of Pennsylvania School of Medicine
Dr. Franklin discusses treatment for children with trichotillomania, Tourette Syndrome, and other body-focused repetitive disorders and their relationship to anxiety disorders.Listen
Need more help for your OCD? Many people with OCD experience only a partial response to currently available medications.
Emory University and multiple sites across the U.S. are seeking volunteers to participate in a clinical trial evaluating the effectiveness of low-dose ondansetron augmentation for the treatment of OCD in patients who have not adequately responded to their current SRI therapy after at least 12 weeks of stable treatment.
Participants must have a DSM-IV-TR diagnosis of OCD as their primary disorder who have been on a stable treatment regimen of clomipramine, fluvoxamine, fluoxetine, paroxetine, or sertraline for at least 6 weeks may be eligible for this study. Six additional weeks of stable SRI treatment, without adequate clinical response, will be required prior to randomization, after which the participant will receive SRI plus study drug, for a total of 12 more weeks.
Exclusion critera include, but are not restricted to the following:
This study is investigating what, if any, changes in brain chemistry take place in adults with OCD as a result of cognitive behavioral therapy (CBT). We will measure amounts and distribution of glutamate in the brain using MRSI (Magnetic Resonance Spectroscopic Imaging) scans before and after 4 weeks of CBT.
The study offers: